Table 1.
Target | Percent positivity (%) | Mean CTa (SD) | |||||
N1 | N2 | RNAseP | Overall | N1 | N2 | RNAseP | |
RNA conc. (Copies/μL) | |||||||
140 (n = 5) | 100 | 100 | 100 | 100 | 29.1 (1.2) | 31.1 (1.6) | 32.5 (1.4) |
111 (n = 9) | 100 | 100 | 89 | 100 | 30.3 (1.6) | 32.3 (0.8) | 31.0 (4.2) |
56 (n = 10) | 100 | 100 | 90 | 100 | 31.6 (1.3) | 34.5 (0.8) | 33.8 (3.9) |
28 (n = 5) | 100 | 100 | 100 | 100 | 32.6 (0.9) | 35.0 (0.9) | 35.7 (2.4) |
6 (n = 10) | 80 | 90 | 100 | 100 | 34.4 (1.1) | 36.2 (1.5) | 34.5 (1.2) |
3 (n = 10) | 60 | 70 | 90 | 90 | 34.3 (0.5) | 36.2 (1.1) | 34.3 (1.1) |
0.6 (n = 10) | 40 | 30 | 90 | 50 | 34.0 (0.7) | 36.2 (1.7) | 34.4 (1.6) |
CT, cycle threshold; RT-PCR, reverse transcriptase polymerase chain reaction; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.
Calculated for detected samples.